Eric Schmidt on joining Cantor Fitzgerald and his thoughts on the year ahead
Cantor Fitzgerald biotech analyst Eric Schmidt talks about themes he thinks will work in 2024, tracking important sickle cell and Alzheimer's launches, TCR programs, and more.